• Videha Sharma, Reuben Roy, Oana Piscoran, Angela Summers, David van Dellen, and Titus Augustine.
• Manchester University Hospitals NHS Foundation Trust, Manchester, UK and University of Manchester, Manchester, UK videha.sharma@postgrad.manchester.ac.uk.
• Clin Med (Lond). 2020 May 1; 20 (3): 346348346-348.

AbstractTransplantation is the preferred treatment option for end-stage renal disease as it offers superior results and patient reported outcomes in comparison to dialysis. Patients treated with a transplant live longer, healthier and more independent lives. Transplantation is also more cost-effective, reducing the overall burden of renal disease. Despite the rising incidence of renal failure, the uptake of living donor kidney transplantation has been static across the UK for several years. Among transplantation, living donation offers a number of advantages compared with deceased donor transplantation. The procedure is more likely to be performed pre-dialysis and the elective nature allows for better perioperative planning. Awareness for living donation processes among healthcare professionals, patients and the public appears to be poor. Sharing information regarding the process will help educate colleagues, dispel myths and, crucially, allow patients the opportunity to talk about this treatment option with their hospital doctor.© Royal College of Physicians 2020. All rights reserved.

12 keywords...

hide…